{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:51:13Z","timestamp":1790844673675,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1097\/md.0000000000010409","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T06:29:19Z","timestamp":1523428159000},"page":"e0409","source":"Crossref","is-referenced-by-count":28,"title":["Cardioprotective effect of histamine H2 antagonists in congestive heart failure"],"prefix":"10.1097","volume":"97","author":[{"given":"Juan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ke","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suo-Chao","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-Hao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-71-20210309","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pcad.2011.04.002","article-title":"Epidemiology and cost of advanced heart failure","volume":"54","author":"Norton","year":"2011","journal-title":"Prog Cardiovasc Dis"},{"key":"R2-71-20210309","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/humupd\/dmn014","article-title":"Effects of histamine and diamine oxidase activities on pregnancy: a critical review","volume":"14","author":"Maintz","year":"2008","journal-title":"Hum Reprod Update"},{"key":"R3-71-20210309","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/01.CIR.97.10.971","article-title":"Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy","volume":"97","author":"Patella","year":"1998","journal-title":"Circulation"},{"key":"R4-71-20210309","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI25713","article-title":"Cardiac mast cell-derived rennin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia\/reperfusion","volume":"116","author":"Mackins","year":"2006","journal-title":"J Clin Invest"},{"key":"R5-71-20210309","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/00004872-200310000-00022","article-title":"A role for cardiac mast cells in the pathogenesis of hypertensive heart disease","volume":"21","author":"Shiota","year":"2003","journal-title":"J Hypertens"},{"key":"R6-71-20210309","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jjcc.2016.04.018","article-title":"Mast cells are increased in the media of coronary lesions in patients with myocardial infarction and may favor atherosclerotic plaque instability","volume":"69","author":"Kupreishvili","year":"2017","journal-title":"J Cardiol"},{"key":"R7-71-20210309","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1084\/jem.20002036","article-title":"Evidence for a role of mast cells in the evolution to congestive heart failure","volume":"195","author":"Hara","year":"2002","journal-title":"J Exp Med"},{"key":"R8-71-20210309","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.103.063065","article-title":"Histamine H1 and H2 receptor gene and protein levels are differentially expressed in the hearts of rodents and humans","volume":"309","author":"Matsuda","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R9-71-20210309","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1038\/sj.bjp.0706440","article-title":"Histamine and its receptors","volume":"147","author":"Parsons","year":"2006","journal-title":"Br J Pharmacol"},{"key":"R10-71-20210309","doi-asserted-by":"crossref","first-page":"R774","DOI":"10.1152\/ajpregu.90466.2008","article-title":"Histamine induces postprandial tachycardia through a direct effect on cardiac H2-receptors in pythons","volume":"296","author":"Skovgaard","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R11-71-20210309","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0002-9149(82)90298-3","article-title":"Histamine and the heart: the other receptor system","volume":"49","author":"Bristow","year":"1982","journal-title":"Am J Cardiol"},{"key":"R12-71-20210309","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00395-013-0342-4","article-title":"Histamine H2 receptor activation exacerbates myocardial ischemia\/reperfusion injury by disturbing mitochondrial and endothelial function","volume":"108","author":"Luo","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"R13-71-20210309","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1572-0241.2003.07186.x","article-title":"Who is using chronic acid suppression therapy and why?","volume":"98","author":"Jacobson","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R14-71-20210309","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00395-010-0119-y","article-title":"A histamine H2 receptor blocker ameliorates development of heart failure in dogs independently of beta-adrenergic receptor blockade","volume":"105","author":"Takahama","year":"2010","journal-title":"Basic Res Cardiol"},{"key":"R15-71-20210309","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.yjmcc.2006.02.001","article-title":"Blockade of histamine H2 receptors protects the heart against ischemia and reperfusion injury in dogs","volume":"40","author":"Asanuma","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"R16-71-20210309","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2006.05.069","article-title":"Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies","volume":"48","author":"Kim","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R17-71-20210309","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jacc.2016.01.045","article-title":"Histamine H2 receptor antagonists, left ventricular morphology, and heart failure risk: The MESA study","volume":"67","author":"Leary","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R18-71-20210309","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/0002-9149(93)90987-N","article-title":"Effects of histamine type 2-receptor antagonists cimetidine and famotidine on left ventricular systolic function in chronic congestive heart failure","volume":"72","author":"Solomon","year":"1993","journal-title":"Am J Cardiol"},{"key":"R19-71-20210309","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/j.1875-9114.1998.tb03903.x","article-title":"Effect of oral H2-receptor antagonists on left ventricular systolic function and exercise capacity in patients with chronic stable heart failure","volume":"18","author":"Lucas","year":"1998","journal-title":"Pharmacotherapy"},{"key":"R20-71-20210309","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/clpt.1991.69","article-title":"No effect of famotidine on cardiac performance by noninvasive hemodynamic measurements","volume":"49","author":"Salmon","year":"1991","journal-title":"Clin Pharmacol Ther"},{"key":"R21-71-20210309","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.amjcard.2004.02.025","article-title":"Famotidine and long QT syndrome","volume":"93","author":"Lee","year":"2004","journal-title":"Am J Cardiol"},{"key":"R22-71-20210309","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/gut.32.6.630","article-title":"Negative chronotropic effects of nizatidine","volume":"32","author":"Halabi","year":"1991","journal-title":"Gut"},{"key":"R23-71-20210309","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/0735-1097(92)90329-L","article-title":"Influence of histamine receptors on basal left ventricular contractile tone in humans: assessment using the H2 receptor antagonist famotidine and the beta-adrenoceptor antagonist esmolol as pharmacologic probes","volume":"19","author":"Borow","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"R24-71-20210309","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/0016-5085(89)90503-9","article-title":"Negative effects of famotidine on cardiac performance assessed by noninvasive hemodynamic measurements","volume":"96","author":"Kirch","year":"1989","journal-title":"Gastroenterology"},{"key":"R25-71-20210309","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/clpt.1990.153","article-title":"Hemodynarnic effects of different H2-receptor antagonists","volume":"48","author":"Hinrichsen","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"R26-71-20210309","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/j.1875-9114.1995.tb04349.x","article-title":"Comparative evaluation of the hemodynamic effects of oral cimetidine, ranitidine, and famotidine as determined by echocardiography","volume":"15","author":"Welage","year":"1995","journal-title":"Pharmacotherapy"},{"key":"R27-71-20210309","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2125.1993.tb04170.x","article-title":"Dose-dependent heart rate reducing effect of nizatidine, a histamine H2-receptor antagonist","volume":"35","author":"Hinrichsen","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"R28-71-20210309","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF00227351","article-title":"Haemodynamic effects of roxatidine, an H2-receptor antagonist","volume":"70","author":"Halabi","year":"1992","journal-title":"Clin Investig"},{"key":"R29-71-20210309","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/clpt.1992.29","article-title":"Hemodvnarnic effects ot quinidine and famotidhe in patients with congestive heart failure","volume":"51","author":"Kirch","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"R30-71-20210309","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3109\/00365529209011178","article-title":"Cardiovascular effects of omeprazole and famotidine","volume":"27","author":"Halabi","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"R31-71-20210309","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R32-71-20210309","doi-asserted-by":"crossref","first-page":"H45","DOI":"10.1152\/ajpheart.00939.2005","article-title":"Evidence for histamine as a neurotransmitter in the cardiac sympathetic nervous system","volume":"291","author":"Li","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R33-71-20210309","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1471-4159.2008.05532.x","article-title":"Sympathetic histamine exerts different pre- and post-synaptic functions according to the frequencies of nerve stimulation in guinea pig vas deferens","volume":"106","author":"He","year":"2008","journal-title":"J Neurochem"},{"key":"R34-71-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/molmed.2011.00225","article-title":"Arrhythmogenic effect of sympathetic histamine in mouse hearts subjected to acute ischemia","volume":"18","author":"He","year":"2012","journal-title":"Mol Med"},{"key":"R35-71-20210309","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fphys.2013.00323","article-title":"New advances in beta blocker therapy in heart failure","volume":"4","author":"Barrese","year":"2013","journal-title":"Front Physiol"},{"key":"R36-71-20210309","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20130716","article-title":"Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis","volume":"127","author":"Zeng","year":"2014","journal-title":"Clin Sci (Lond"},{"key":"R37-71-20210309","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.yjmcc.2010.09.019","article-title":"\u03b22 AR agonists in treatment of chronic heart failure: long path to translation","volume":"54","author":"Talan","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"R38-71-20210309","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ppedcard.2010.11.007","article-title":"The role of \u03b2-adrenergic receptors in heart failure: differential regulation of cardiotoxicity and cardioprotection","volume":"31","author":"Bernstein","year":"2011","journal-title":"Prog Pediatr Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000010409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T18:24:15Z","timestamp":1720203855000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201804130-00071"}},"subtitle":["A systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000010409","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}